Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses

Trial Profile

Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses

Recruiting
Phase of Trial: Phase II

Latest Information Update: 02 May 2016

At a glance

  • Drugs Tinzaparin sodium (Primary)
  • Indications Thrombosis
  • Focus Therapeutic Use
  • Acronyms STRIP
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 31 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top